Skip to main content
Figure 4 | BMC Pulmonary Medicine

Figure 4

From: Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapy

Figure 4

Kaplan-Meier curves demonstrating the impact of functional class (A and B) and 6MWD (C and D) 3 months after introduction of intravenous iloprost on the LuTx-free and overall survival from the time point iloprost-start. LuTx-free survival: Hazard ratio NYHA IV vs. III 3.87; 95% CI 1.38-10.84; Hazard ratio 6MWD < 300 m vs. > 300 m 3.14, 95% CI 1.17-8.45. Overall survival: Hazard ratio of NYHA IV vs. NYHA III: 8.39, 95% CI 2.28-30.83; Hazard ratio of 6MWT < 300 m vs. > 300 m: 8.76, 95% CI 2.05-37.5. |: censored patients.

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us